9DDL image
Deposition Date 2024-08-28
Release Date 2025-06-11
Last Version Date 2025-06-11
Entry Detail
PDB ID:
9DDL
Keywords:
Title:
Glutathione transferase sigma class from Taenia solium 1.3
Biological Source:
Source Organism:
Taenia solium (Taxon ID: 6204)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.30 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.19
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Sigma-type glutathione S-transferase
Gene (Uniprot):GST-28
Chain IDs:A
Chain Length:212
Number of Molecules:1
Biological Source:Taenia solium
Ligand Molecules
Primary Citation
Structural insights into sigma class glutathione transferase from Taenia solium: Analysis and functional implications.
Plos Negl Trop Dis 19 e0013024 e0013024 (2025)
PMID: 40445974 DOI: 10.1371/journal.pntd.0013024

Abstact

Neglected tropical diseases pose a significant threat to global health, especially in low- and middle-income countries where treatment options are inadequate and transmission risk factors persist. One example is neurocysticercosis caused by Taenia solium. Sigma class glutathione transferases (Sigma GSTs) are key regulators of Th1 inflammatory responses, making them promising targets for development of therapies and vaccines. This study presents the first report on the crystallographic structures of recombinant 24-kDa sigma class GST from T. solium (rTs24GST), which were determined at resolutions of 1.30 and 1.75 Å. The apo-form structures show the typical GST fold with distinct N- and C-terminal domains and highlight regions of notable flexibility near the G-site. Molecular dynamics simulations show that the presence of glutathione stabilizes the enzyme and reduces conformational fluctuations. Comparative analysis with other GSTs revealed conserved flexible regions that correlate with glutathione binding. These structural insights into rTs24GST can be associated with evolutionary adaptations for interacting with diverse substrates and could open new avenues for developing inhibitors and therapeutic strategies against neurocysticercosis.

Legend

Protein

Chemical

Disease

Primary Citation of related structures